Literature DB >> 33578581

Duodenal neuroendocrine tumor: A rare case report.

Xuewen Wang1, Yanbin Wu1, Xuefeng Cao1, Xingyuan Zhang1, Yu Cheng1,2, Lingqun Kong1.   

Abstract

RATIONALE: Duodenal neuroendocrine tumor (d-NET) is a rare tumor originating in the neuroendocrine system. The clinical manifestations of d-NET are similar to those of other digestive tract tumors, resulting in a lack of specificity and complex clinical symptoms. PATIENT CONCERNS: A 55-year-old female patient was admitted to our hospital with a chief complaint of an abdominal mass that had been present for more than 4 months. DIAGNOSES: The upper abdomen enhanced computed tomography scan showed an uneven density mass across the upper abdomen, and the tumor size was approximately 6.2 × 5.8 cm with obvious visible enhancement present in 1 area and a cystic nonenhanced area. The postoperative pathology showed the tumor cells to be positive for chromogranin, synaptophysin, cytokeratin, CD56 (partial weak), negative for vimentin, CD117, DOG-1, CD34, S-100, SMA, desmin, and Ki-67 approximately 2%, which confirmed the diagnosis of d-NETs.
INTERVENTIONS: We preferred laparoscopic surgical exploration, but the tumor started at the ascending part of the duodenum and involved the mesenteric artery. As the branches of the superior mesenteric artery were intertwined with the tumor, it was difficult to operate with the endoscope, so we converted to open laparotomy. The postoperative pathology revealed the presence of d-NET. OUTCOMES: The patient recovered uneventfully and was discharged after the operation. One-month and 3-month follow-up after surgery, showed no evidence of recurrence. LESSONS: Radiological imaging studies are insufficient for the differential diagnosis of abdominal mass from other diseases, whereas surgery is the only radical treatment method, and the preferred surgical method is still active radical resection of the tumor.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33578581      PMCID: PMC7886419          DOI: 10.1097/MD.0000000000024635

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  11 in total

1.  Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Pao-Yuan Huang; Kai-Lung Tsai; Chih-Ming Liang; Wei-Chen Tai; Kun-Ming Rau; Keng-Liang Wu; Chao-Cheng Huang; Seng-Kee Chuah
Journal:  Kaohsiung J Med Sci       Date:  2018-06-20       Impact factor: 2.744

2.  Radical surgical resection for carcinoid tumors of the ampulla.

Authors:  Shin Hwang; Sung-Gyu Lee; Young-Joo Lee; Duck-Jong Han; Song-Cheol Kim; Sea-Hyun Kwon; Je-Ho Ryu; Jung-Ik Park; Hyo-Jun Lee; Ga-Won Choi; Eun-Sil Yu
Journal:  J Gastrointest Surg       Date:  2007-11-09       Impact factor: 3.452

Review 3.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

4.  Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: Results from the large database of a multidisciplinary group clinical multicenter study.

Authors:  Juan Manuel O'Connor; Fabiana Marmissolle; Claudia Bestani; Veronica Pesce; Susana Belli; Enzo Dominichini; Guillermo Mendez; Paola Price; Nora Giacomi; Alejandro Pairola; Fernando Sánchez Loria; Eduardo Huertas; Claudio Martin; Karina Patane; Claudia Poleri; Moises Rosenberg; Ana Cabanne; Mirta Kujaruk; Analia Caino; Victor Zamora; Javier Mariani; Mariano Dioca; Patricia Parma; Gustavo Podesta; Oscar Andriani; Gabriel Gondolesi; Enrique Roca
Journal:  Mol Clin Oncol       Date:  2014-06-27

5.  Duodenal Neuroendocrine Tumors: Location Matters!

Authors:  Mohd Raashid Sheikh; Houssam Osman; Susannah Cheek; Shanee Hunter; Dhiresh Rohan Jeyarajah
Journal:  Am Surg       Date:  2016-05       Impact factor: 0.688

6.  Neuroendocrine tumors of the ampulla of vater: presentation, pathology and prognosis.

Authors:  Mayank Jayant; Rajpal Punia; Robin Kaushik; Rajeev Sharma; Atul Sachdev; Nikhil K Nadkarni; Ashok Attri
Journal:  JOP       Date:  2012-05-10

7.  Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms.

Authors:  Alexander Koenig; Sebastian Krug; Daniela Mueller; Peter J Barth; Ute Koenig; Michael Scharf; Volker Ellenrieder; Patrick Michl; Roland Moll; Kia Homayunfar; Peter Herbert Kann; Philipp Stroebel; Thomas M Gress; Anja Rinke
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

8.  Comparisons of therapeutic outcomes in patients with nonampullary duodenal neuroendocrine tumors (NADNETs): A multicenter retrospective study.

Authors:  Seung Woo Lee; Jae Kyu Sung; Young Sin Cho; Ki Bae Bang; Sun Hyung Kang; Ki Bae Kim; Sae Hee Kim; Hee Seok Moon; Kyung Ho Song; Sun Moon Kim; Il-Kwun Chung; Dong Soo Lee; Hyun Yong Jeong; Sei Jin Youn
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

9.  Clinicopathological features and surgical outcomes of neuroendocrine tumors of ampulla of Vater.

Authors:  Kwangho Yang; Sung Pil Yun; Suk Kim; Nari Shin; Do Youn Park; Hyung Il Seo
Journal:  BMC Gastroenterol       Date:  2017-05-31       Impact factor: 3.067

10.  Clinical outcomes of ligation-assisted endoscopic resection for duodenal neuroendocrine tumors.

Authors:  Su Bum Park; Dae Hwan Kang; Cheol Woong Choi; Hyung Wook Kim; Su Jin Kim
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.